Curis (CRIS) Tops Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall St futures mixed ahead of CPI, bank earnings; US-Iran tensions in focus
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Curis (CRIS) PT Lowered to $3 at Baird
November 1, 2018 1:58 PM EDTBaird analyst Brian Skorney lowered the price target on Curis (NASDAQ: CRIS) to $3.00 (from $6.00) while maintaining a Outperform rating after management outlined plans to refocus efforts toward the three clinical program.
"Pivoting development of CA-170 away from PD-1/L1 eligible patients and... More
